. . : , . , 2005, 3, . 18-20). 42 Wakefield A. et al. Heal nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 1998; 351:637-41.
5 7043. , MMR. , 44 ( , ).
80- 90- . , , , 45. . - , (, , . . ?), , ( ) , . , MMR, , . , 46, , - - . 28 2000 . - . ,
43 Uhlmann V. et al. Potential viral pathogenic mechanism for new variant inflammatory bowel
disease. Molecular Pathology 2002; 55(2):84-90.
44 Kielinen M. et al. Autism in Northern Finland. Eur. Child. Adolesc. Psychiatry Sept 2000;
9:162-7.
45 , - , -
, 9 ( 7 ),
,
, , ,
-
, , .
46 Taylor . et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence
for a causal association. Lancet June 12, 1999; 353(9169):2026-9. ,
, - ,
.
|
|
, MMR. ( ) , , MMR 47. . , , , , , MMR48. , MMR 1993 . 49. , : MMR, , , , , MMR...
. , , MMR , . , .
, . . ( , ). ,
47 Madsen . . et al. A population-based study of measles, mumps, and rubella vaccination and
autism. N. Engl. J. Med. Nov 7, 2002; 347(19):1477-82.
48 Goldman G. S., Yazbak E. F. An investigation of the association between MMR vaccination
and autism in Denmark. Journal of American Physicians & Surgeons 2004; 9(3):70-75.
49 Honda H. et al. No effect of MMR withdrawal on the incidence of autism: a total population
study. Journal of Child Psychology and Psychiatry 2005, 46(6).
, 75 , , . , , , , . , - ( !) 50. , , DTaP , , , 51. , , (). , , . , ( , ). , . , 52. , , (!)
|
|
50 Sikker W. Developmental neurotoxicology of therapeutics: survey of novel recent findings.
Neurotoxicology 2000; 21:250.
551Cm. Geier M. R., Geier D. A. Neurodevelopmental Disorders Following Thimerosal-Contain-
ing Vaccines. Experimental Biology & Medicine 2003; 228:660664, Geier M. R., Geier D. A.
Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United
States. Journal of American Physicians & Surgeons 2003; 8(1):6-11, Geier D. A., Geier M. R.
An Assessment of the Impact of Thimerosal on Childhood Neurodevelopmental Disorders. Pe-
diatric Rehabilitation 2003; 6:97-102.
52 Geier D.A., Geier M. R. Early Downward Trends in Neurodevelopmental Disorders Following
Removal of Thimerosal-Containing Vaccines. Journal of American Physicians and Surgeons
2006; 11(1): 8-13.
, . : (Evidences of Harm: Mercury in Vaccines and the Autism Epidemic A Medical Controversy) 2005 . , , , , , 2006 . - (National Institute for Environmental Health Sciences).
(- ) . . , , , , . , (, , MMR). , , , , . , . . , , MMR53. MMR , (), ,
|
|
53 . Singh V. . Immunotherapy for brain disease and mental illnesses. Progress in Drug Research 1997; 48:129-146, Singh V. K. et al. Antibodies to myelin basic protein in children with autistic disorder. Brain Behavior and Immunity 1997; 7:97-103, Singh V. K. et al. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 1998; 89:105-108, Singh V. K. Neuroimmunopathogenesis in autism. In: Neurolmmune Biology: New Foundation of Biology 2001; vol. 1:443-454, Singh V. K. et al. Abnormal measles-mumps-rubella antibodies and autoimmunity in children with autism. Journal of Biomedical Science 2002; 9:359-364, Singh V. K., Jensen R. L. Elevated levels of measles antibodies in children with autism. Pediatric Neurology 2003; 28:292-294.
MMR, . , MMR, , , , MMR.
(Amish) , 150 . , ( )54, , ( , , ). , , , 1- , ...55
MMR , . , , MMR . , - , , (single jobs clinics), . , - , , , MMR , , . -
54 , 3
, ( ,
). ,
(Christian Science)
,
,
.
55 OlmstedD. The Age of Autism: 'A pretty big secret'. United Press International, Dec. 7,2005.
, , , , MMR , , 56. , MMR, .
|
|
, MMR-II, ( MMR, ) ( ). (), -16 -5. . , . -18 57.
12-15 ( 6-7 ). 9 . . , , . , , , 58, . , . . , , . , , .
56 , , , , , , () 29 2004 ., - -, .
57 . ., . . . . ., 2001, 136.
58 Christenson ., Bottiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity toand booster effects on the measles virus. Vaccine Feb 1994; 12:129-33.
. 12-15 59. 5-9 , 15 99% . , , . , , 60, ( , , , , , 61; , ). , 1. , , ( 920,6%) 2. , , , 62,20,7%, , , (60,20,7%), , (75,20,9%)62.
59 ( . . .)
1 , ( . .
... . 264).
60 ,
. 1984 . :
,
. , -
, .
... ( . . ... . 31). -
, , ,
- .
|
|
61 Adu F. D., AdenijiJ. A. Measles antibodies in the breast milk of nursing mothers. Afr. J. Med.
Sci. Dec 1995; 24:385-8.
62 . . .
, 2000, 1, 17-19.
. -
. -
() -
, . , 95% 9 95% , 12 , , , , , 1963 ., 63. ( 1997-1998 .) . , , (24,6 100 . 5,5 100 . 64) 65. , , . , 1985 ., , 15 14% 66. , , . 1985-1995 . ( 19 ) , , -, , -, . 10 21,3%, 1993-1995 ., 29,5%,
. , , ( , , .). , , . , , , . , .
63 Maldonado ¥. A. et al. Early loss of passive measles antibody in infants of mothers with vac
cine-induced immunity. Pediatrics Sept 1995; 96:447-50.
64 Janaszek W., Slusarczyk J. Immunity against measles in populations of women and infants in
Poland. Vaccine June 2003; 21:2948-53.
65 111 , , 6 . (Dayton L. Measles Vaccination May Not Protect for Life. New Scientist (Canada) November 1989; vol. 4 p. 6).
66 Tobias M. et al. Measles immunity in children: the 1985 national immunisation survey NZ Med. J. May 27, 1987;100(824):315-7.
67. ? ! 1967 . 15 0,2-0,3%, 1987 . 31%. , , , . , , , ( . . .)68. - -, , : ( , ) 95%, , , 60% , 70%, 80%, 90%, 95%, ( , , ), , 99% ...69.
, MMR, , , , 70. , ,
67 Miller M. etal. Measles among adults, United States, 1985-1995. Am. J. Prev. Med. Aug 1999;
17:114-9.
68 . . ... . 271.
69 . . 10. - : , , , - , . ; , , ; , , . , , , , . , , . , ; , , , .
70 . Papania M. et al. Increased susceptibility to measles in infants in the United States. Pediatrics Nov 1999; 104:e59, , , 1963 . ( ), , , 1963 .
. , , , , .
, , 2005 . . , , , ( , ), . , , . , . , . , , . , . , , .
1980- ., , : 0,06% 17,8%71. , , , 300 .
. (. ) . : ! ( , ). 1980- . , 20 40% . -
71 . . ... . 30.
18 , , 71 99,8% . , 1989 . 1363 99%- 72 ( , ?). , . : - 73.